Biochemistry, Genetics and Molecular Biology
Proteomics
31%
Tumor Progression
28%
AKT1
28%
Macrophage
27%
MicroRNA
25%
Fibulin
25%
Dynamics
25%
Tumor-Associated Macrophage
25%
Tumor Spheroid
24%
Coculture
20%
Genetics
18%
KLF4
15%
Methylation
15%
Genomics
12%
Phosphoprotein
12%
Genotyping
12%
HK2
12%
STAT1
12%
Transcription
12%
RNA Metabolism
12%
Epidermal Growth Factor
12%
S100A4
12%
Mesenchymal-Epithelial Transition
12%
Plasmid
12%
Proteomics
12%
Next Generation Sequencing
12%
Monolayer Culture
12%
Real-Time Polymerase Chain Reaction
11%
Immunocompetent Cell
10%
Epidermal Growth Factor Receptor
10%
Polymerase Chain Reaction
9%
Cell Proliferation
8%
Genetic Background
8%
Liquid Chromatography-Mass Spectrometry
8%
Carcinogenesis
8%
CD163
7%
Western Blot
7%
Clinical Trial
6%
Bulk RNA Sequencing
6%
Peripheral Blood Mononuclear Cell
6%
Chromosome 22
6%
Mutated Genes
6%
Nonsense Mutation
6%
Splice Site Mutation
6%
Chromosome 22q
6%
Protein Expression
6%
Cre Recombinase
6%
Receptor Gene
6%
Southern Blotting
6%
DNA Sequence
6%
Pharmacology, Toxicology and Pharmaceutical Science
Meningioma
100%
Biological Marker
60%
Neoplasm
40%
Malignant Meningioma
37%
microRNA
27%
microRNA 9
25%
Fibulin
25%
Tumor Growth
15%
Merlin
12%
Transcription Factor GATA 4
12%
Selumetinib
12%
Epidermal Growth Factor
12%
Tumor Microenvironment
10%
Recurrence Risk
8%
Cyclin D1
7%
Epidermal Growth Factor Receptor
6%
Intracranial Tumor
6%
Carcinogenesis
5%
Fibrinogen
5%
Cullin
5%
Brain Tumor
5%
Immunology and Microbiology
Neopterin
25%
Kidney Allograft Rejection
25%
Transplant Procedure
17%
Acute Graft Rejection
17%
Affinity Maturation
12%
Interleukin 12 Subunit Beta
12%
Lysozyme
12%
Antigen
12%
Germinal Center
12%
Interferon Gamma
12%
Plasmid
12%
Transcription Factor GATA 4
12%
Immune Response
10%
Duck
7%
Transgenics
7%
Somatic Hypermutation
7%
B Cell
7%
Antimicrobial Resistance
6%
Southern Blotting
6%
Receptor Gene
6%
Polymerase Chain Reaction
6%
DNA Sequence
6%
Yeast Cell
6%
Saccharomyces cerevisiae
6%
Hen
5%
Single Nucleotide Polymorphism
5%
Interferon Type I
5%